Australia's ResApp Health Limited has entered into a binding scheme implementation deed with Pfizer Australia Holdings P...
Many neurological disorders like Parkinson’s, chronic depression and other psychiatric conditions could be managed...
Australian and US MedTech startup Nutromics (Nutromics or the Company), a global leader in DNA-based biosensors, announc...
Australia's Telix Pharmaceuticals has entered into a licence agreement with Eli Lilly and Company under which Telix is g...
Medriva, a leading global manufacturer of COVID-19 testing and vaccination products, has announced the Australian a...
A new study led by Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisati...
Telix Pharmaceuticals Limited welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomogr...
Microba Life Sciences, a precision microbiome science company, and Ginkgo Bioworks , the leading horizontal platfor...
Monash University has officially launched Australia’s first industry-focused storage facility for biological mater...
Trescal, the global leader in calibration services, has announced the launch of its single source instrumentation soluti...
Australia-based Microba Life Sciences commences trading on the Australian Securities Exchange following the completion o...
Australia's Telix Pharmaceuticals announced that its prostate cancer imaging agent, Illuccix (kit for preparation o...
Telix Pharmaceuticals has announced that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) P...
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...
Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...
Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from toda...
US-based Sonoma Pharmaceuticals, a global healthcare leader developing and producing patented Microcyn technology based ...
Australian Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used to continue ...
